DEA Wants to Reschedule Magic Mushrooms: Big Change Coming! #shorts
29 May 2026 · 1 min

0:30
In this brief commentary, the speaker highlights a pivotal shift in U.S. drug policy: the Drug Enforcement Administration (DEA) has formally asked the Department of Health and Human Services (HHS), currently led by RFK Jr., to recommend moving psilocybin—the psychoactive compound in magic mushrooms—out of Schedule I. The speaker connects this request to the recent reclassification of cannabis, which was downgraded from Schedule I to Schedule III, a change that now permits scientific research and physician‑prescribed medical use. By drawing a parallel between the two substances, the speaker suggests that psilocybin may soon follow a similar path, opening doors for clinical studies and therapeutic applications.











